We are live on ! Find out more
BLU

BELLUS Health Inc.
BLU

Delisted

BLU was delisted on the 28th of June, 2023.

Back to rankings

64 hedge funds and large institutions have $376M invested in BELLUS Health Inc. in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

33% more funds holding

Funds holding: 48 → 64 (+16)

13% more capital invested

Capital invested by funds: $334M → $376M (+$42.2M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
64
Holders Change
+16
Holders Change %
+33.33%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
24
Increased
20
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$15.7M
2
EAM
Eventide Asset Management
Massachusetts
+$15.6M
3
PA
Perceptive Advisors
New York
+$11.4M
4
MWNA
Marshall Wace North America
New York
+$9.68M
5
RSCM
Rock Springs Capital Management
Maryland
+$7.06M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$19.1M
2
PC
Polar Capital
United Kingdom
-$16M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.99M
4
EGI
EAM Global Investors
California
-$5.44M
5
First Manhattan
First Manhattan
New York
-$4.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
26
Mangrove Partners
Connecticut
$2.14M -$3.1M -305,906 -60%
Bank of Montreal
27
Bank of Montreal
Ontario, Canada
$1.75M +$5.58M +550,350 +3,469%
AG
28
Artal Group
Luxembourg
$1.48M +$1.46M +143,763 New
Millennium Management
29
Millennium Management
New York
$1.3M +$1.28M +126,326 New
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$1.15M -$682K -67,290 -38%
SFM
31
Sphera Funds Management
Israel
$1.01M +$991K +97,805 New
Swiss National Bank
32
Swiss National Bank
Switzerland
$896K +$884K +87,200 New
Deutsche Bank
33
Deutsche Bank
Germany
$884K +$871K +85,921 New
Renaissance Technologies
34
Renaissance Technologies
New York
$677K +$54.1K +5,339 +9%
TD Asset Management
35
TD Asset Management
Ontario, Canada
$666K +$335K +33,033 +104%
Two Sigma Investments
36
Two Sigma Investments
New York
$506K +$499K +49,200 New
WMSA
37
Weiss Multi-Strategy Advisers
New York
$465K +$16.6K +1,638 +4%
Ensign Peak Advisors
38
Ensign Peak Advisors
Utah
$418K +$207K +20,433 +101%
Goldman Sachs
39
Goldman Sachs
New York
$389K – – –
Geode Capital Management
40
Geode Capital Management
Massachusetts
$357K +$137K +13,529 +64%
UBS AM
41
UBS AM
Illinois
$321K +$315K +31,100 New
CSS
42
Cubist Systematic Strategies
Connecticut
$306K +$301K +29,706 New
Vanguard Group
43
Vanguard Group
Pennsylvania
$259K +$256K +25,215 New
Northern Trust
44
Northern Trust
Illinois
$231K +$4.54K +448 +2%
CS
45
Credit Suisse
Switzerland
$196K +$193K +19,089 New
FDCDDQ
46
Federation des caisses Desjardins du Quebec
Quebec, Canada
$146K -$9.5K -937 -6%
BFM
47
Boothbay Fund Management
New York
$126K +$123K +12,183 New
Verition Fund Management
48
Verition Fund Management
Connecticut
$103K – – –
Bank of America
49
Bank of America
North Carolina
$80K -$16K -1,577 -17%
Zurich Cantonal Bank
50
Zurich Cantonal Bank
Switzerland
$61K +$59.2K +5,839 New
1
2
3

BLU Hedge Fund Activity: Q2 2020 in Review

64 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q2 2020, worth a combined $376M — up 13% from $334M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new BLU positions and 8 closed out — a net gain of 16 holders — while 20 added to existing stakes and 12 trimmed.

The largest buyer was Cowen and Company, adding an estimated $15.7M. The largest seller was OrbiMed, cutting an estimated $19.1M.

  • 64 institutional investors held BELLUS Health Inc. (BLU) as of Q2 2020, up from 48 in Q1 2020.
  • Funds reported $376M of BELLUS Health Inc. stock for Q2 2020, up 13% quarter-over-quarter.
  • 24 funds opened new BELLUS Health Inc. positions in Q2 2020 and 8 closed out, a net change of +16 holders.
  • The largest BELLUS Health Inc. buyer in Q2 2020 was Cowen and Company, an estimated $15.7M added.
  • The largest BELLUS Health Inc. seller in Q2 2020 was OrbiMed, an estimated $19.1M sold.

Based on aggregated 13F filings for Q2 2020.